tradingkey.logo

BRIEF-Exosens FY Adjusted EBITDA Up 37.8% To EUR 118.5 Million

ReutersMar 3, 2025 6:41 AM

- Exosens SAS EXENS.PA:

  • FY 2024 REVENUE GROWS 35% TO €394.1M

  • FY 2024 NET PROFIT UP 66.7% TO €30.7M

  • CONTINUED STRONG PERFORMANCE EXPECTED IN 2025, WITH REVENUE GROWTH IN THE HIGH-TEENS AND ADJUSTED EBITDA GROWTH IN THE LOW TWENTIES

  • FY 2024 ADJUSTED EBITDA UP 37.8% TO €118.5M

  • NET LEVERAGE AT 1.2X YEAR-END 2024

  • PROPOSES €0.10 CASH DIVIDEND PER SHARE FOR FY 2024

  • TO INVEST €20M TO EXPAND PRODUCTION CAPACITY IN EUROPE, US WITH NEW PRODUCTION PLANT IN THE US, TO GIVE ADDITIONAL MARKET OPPORTUNITIES

  • HIGH-TEENS 2024-2026 ADJUSTED EBITDA CAGR

Source text: ID:nGNE1K7w17

Further company coverage: EXENS.PA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI